Skip to Main Content

Author Details

Esther Herpel
Institute of Pathology, University Hospital Heidelberg
2005
196
43
PMIDPaper TitleJournal TitlePublished Year
36811271Bovine meat and milk factor protein expression in tumor-free mucosa of colorectal cancer patients coincides with macrophages and might interfere with patient survival.Mol Oncol2024
37963432CD15 Is a Risk Predictor and a Novel Target in Clear Cell Renal Cell Carcinoma.Pathobiology2024
34648658Tumor DNA-methylome derived epigenetic fingerprint identifies HPV-negative head and neck patients at risk for locoregional recurrence after postoperative radiochemotherapy.Int J Cancer2022
35768510Mitochondrial RNA modifications shape metabolic plasticity in metastasis.Nature2022
35394006Higher vitamin B6 status is associated with improved survival among patients with stage I-III colorectal cancer.Am J Clin Nutr2022
33595421Differentially methylated regions within lung cancer risk loci are enriched in deregulated enhancers.Epigenetics2022
32949260Response to neoadjuvant treatment among rectal cancer patients in a population-based cohort.Int J Colorectal Dis2021
35822817Harmonization of Biobank Education for Biobank Technicians: Identification of Learning Objectives.BioTech (Basel)2021
33718446Early Detection of Checkpoint Inhibitor-Associated Myocarditis Using <sup>68</sup>Ga-FAPI PET/CT.Front Cardiovasc Med2021
33579312Expression of apoptosis repressor with caspase recruitment domain (ARC) in familial adenomatous polyposis (FAP) adenomas and its correlation with DNA mismatch repair proteins, p53, Bcl-2, COX-2 and beta-catenin.Cell Commun Signal2021
34680330Prognostic Gene Signature for Squamous Cell Carcinoma with a Higher Risk for Treatment Failure and Accelerated MEK-ERK Pathway Activity.Cancers (Basel)2021
34065419Comparative Transcriptomics of Immune Checkpoint Inhibitor Myocarditis Identifies Guanylate Binding Protein 5 and 6 Dysregulation.Cancers (Basel)2021
33933015Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samples.BMC Cancer2021
34359718Clinical Characteristics and Outcomes of Colorectal Cancer in the ColoCare Study: Differences by Age of Onset.Cancers (Basel)2021
30640754BAP1 Loss is a Useful Adjunct to Distinguish Malignant Mesothelioma Including the Adenomatoid-like Variant From Benign Adenomatoid Tumors.Appl Immunohistochem Mol Morphol2020
34317246Cardiac Myxoma in a Patient With Hypertrophic Cardiomyopathy.JACC Case Rep2020
31816156Microsatellite instability and survival after adjuvant chemotherapy among stage II and III colon cancer patients: results from a population-based study.Mol Oncol2020
31897467Association of BMI and major molecular pathological markers of colorectal cancer in men and women.Am J Clin Nutr2020
32075687Circulating 27-hydroxycholesterol and breast cancer tissue expression of CYP27A1, CYP7B1, LXR-β, and ERβ: results from the EPIC-Heidelberg cohort.Breast Cancer Res2020
31802644The chameleon of cardiology: cardiac sarcoidosis before and after heart transplantation.ESC Heart Fail2020
31740522Expression Patterns of Xenobiotic-Metabolizing Enzymes in Tumor and Adjacent Normal Mucosa Tissues among Patients with Colorectal Cancer: The ColoCare Study.Cancer Epidemiol Biomarkers Prev2020
31943160Postmenopausal hormone replacement therapy and colorectal cancer risk by molecular subtypes and pathways.Int J Cancer2020
31881506Prognostic and Predictive Value of Tumor-infiltrating Leukocytes and of Immune Checkpoint Molecules PD1 and PDL1 in Clear Cell Renal Cell Carcinoma.Transl Oncol2020
33142733Genotype-Based Gene Expression in Colon Tissue-Prediction Accuracy and Relationship with the Prognosis of Colorectal Cancer Patients.Int J Mol Sci2020
33134831Circulating Folate and Folic Acid Concentrations: Associations With Colorectal Cancer Recurrence and Survival.JNCI Cancer Spectr2020
32634256Immunohistological expression of oestrogen receptor, progesterone receptor, mammaglobin, human epidermal growth factor receptor 2 and GATA-binding protein 3 in non-small-cell lung cancer.Histopathology2020
32858564Colonoscopy and Reduction of Colorectal Cancer Risk by Molecular Tumor Subtypes: A Population-Based Case-Control Study.Am J Gastroenterol2020
32655010Multi-omics Analysis Reveals Adipose-tumor Crosstalk in Patients with Colorectal Cancer.Cancer Prev Res (Phila)2020
32735781SUMOylation of Enzymes and Ion Channels in Sensory Neurons Protects against Metabolic Dysfunction, Neuropathy, and Sensory Loss in Diabetes.Neuron2020
32674955Rearranged ERG confers robustness to prostate cancer cells by subverting the function of p53.Urol Oncol2020
32619831Antibody selection influences the detection of AR-V7 in primary prostate cancer.Cancer Treat Res Commun2020
32953480Comprehensive serial biobanking in advanced NSCLC: feasibility, challenges and perspectives.Transl Lung Cancer Res2020
33008876Genetic Variants in the Regulatory T cell-Related Pathway and Colorectal Cancer Prognosis.Cancer Epidemiol Biomarkers Prev2020
32555365Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium.Br J Cancer2020
32506842Blood-derived DNA methylation predictors of mortality discriminate tumor and healthy tissue in multiple organs.Mol Oncol2020
32554541Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).Clin Cancer Res2020
32473302Prognostic gene expression signature for high-grade serous ovarian cancer.Ann Oncol2020
32225169Smoking, alcohol consumption and colorectal cancer risk by molecular pathological subtypes and pathways.Br J Cancer2020
31495913Plasma metabolites associated with colorectal cancer stage: Findings from an international consortium.Int J Cancer2020
29101262Genome-wide DNA methylation analysis reveals a prognostic classifier for non-metastatic colorectal cancer (ProMCol classifier).Gut2019
31755748DNA methylation profiling to explore colorectal tumor differences according to menopausal hormone therapy use in women.Epigenomics2019
31783876Karyopherin α2-dependent import of E2F1 and TFDP1 maintains protumorigenic stathmin expression in liver cancer.Cell Commun Signal2019
31806053Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies.J Immunother Cancer2019
31741774Bone marrow expands the repertoire of functional T cells targeting tumor-associated antigens in patients with resectable non-small-cell lung cancer.Oncoimmunology2019
31383898Iron accumulation in tumor-associated macrophages marks an improved overall survival in patients with lung adenocarcinoma.Sci Rep2019
31296182External validation of molecular subtype classifications of colorectal cancer based on microsatellite instability, CIMP, BRAF and KRAS.BMC Cancer2019
31239549A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases.Mod Pathol2019
31402955Lamin-B1 is a senescence-associated biomarker in clear-cell renal cell carcinoma.Oncol Lett2019
31340858A prognostic CpG score derived from epigenome-wide profiling of tumor tissue was independently associated with colorectal cancer survival.Clin Epigenetics2019
31540511Interleukin 21 Receptor/Ligand Interaction Is Linked to Disease Progression in Pancreatic Cancer.Cells2019
  • 1 - 50 of 196

Recommended Authors

Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Career Start Year 2015
Number of shared co-authors 12
Institut de Pathologie Multisite
Career Start Year 2013
Number of shared co-authors 0
Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Universite Laval
Career Start Year 2013
Number of shared co-authors 1
University of Navarra
Career Start Year 2010
Number of shared co-authors 1
Center for Cancer Research, National Cancer Institute
Career Start Year 2008
Number of shared co-authors 8
Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund
Career Start Year 2008
Number of shared co-authors 1
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 0
National Cancer Center Exploratory Oncology Research & Clinical Trial Center
Career Start Year 2008
Number of shared co-authors 0
Institute of Pathology, Medical University of Innsbruck
Career Start Year 2007
Number of shared co-authors 3
University of Pisa
Career Start Year 2006
Number of shared co-authors 1
Lund University
Career Start Year 2003
Number of shared co-authors 5
IEO European Institute of Oncology IRCCS
Career Start Year 2002
Number of shared co-authors 0
Institute of Pathology, Paracelsus Medical University
Career Start Year 2000
Number of shared co-authors 2
University of British Columbia
Career Start Year 2000
Number of shared co-authors 31
St Vincent's Hospital
Career Start Year 1997
Number of shared co-authors 1
Uppsala University
Career Start Year 1997
Number of shared co-authors 1
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1997
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 7
Georgetown University
Career Start Year 1993
Number of shared co-authors 0
Kurume University School of Medicine
Career Start Year 1993
Number of shared co-authors 0
University Hospital Zurich
Career Start Year 1991
Number of shared co-authors 16
Erasme University Hospital, Universite Libre de Bruxelles
Career Start Year 1989
Number of shared co-authors 2
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 3
Center for Cancer Research, National Cancer Institute
Career Start Year 1988
Number of shared co-authors 19
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 4
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 1986
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 1985
Number of shared co-authors 4
Yale University School of Medicine
Career Start Year 1980
Number of shared co-authors 15
Lund University
Career Start Year 1977
Number of shared co-authors 33
University Health Network, University of Toronto
Career Start Year 1972
Number of shared co-authors 11

Collaborators

Institute of Pathology, University Hospital Heidelberg
Co-authored papers 68
German Cancer Research Center (DKFZ)
Co-authored papers 43
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 15
Pathologisches Institut, Universitatsklinikum Heidelberg
Co-authored papers 12
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 9
University of British Columbia
Co-authored papers 8
University of Alberta, Canada Cross Cancer Institute
Co-authored papers 7
University of New South Wales
Co-authored papers 7
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 7
Eberhard Karls University Tubingen
Co-authored papers 7
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 7
University of Calgary
Co-authored papers 7
College of Nursing, University of South Florida
Co-authored papers 7
Westmead Hospital
Co-authored papers 7
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 7
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 7
Mayo Clinic
Co-authored papers 7
Mayo Clinic College of Medicine
Co-authored papers 7
University of Hawaii Cancer Center
Co-authored papers 7
Alberta Health Services-Cancer Care
Co-authored papers 7
University of Cambridge
Co-authored papers 7
University of Cambridge
Co-authored papers 7
Hollings Cancer Center, Medical University of South Carolina
Co-authored papers 7
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 7
Instituto de Salud Carlos III
Co-authored papers 6
David Geffen School of Medicine, University of California at Los Angeles
Co-authored papers 6
University of British Columbia
Co-authored papers 6
Spanish National Cancer Research Centre (CNIO)
Co-authored papers 6
Otto-Friedrich-University Bamberg
Co-authored papers 6
Institute of Clinical Trials and Methodology, University College London
Co-authored papers 6